Skip to main content
. 2022 Aug 10;13:970486. doi: 10.3389/fimmu.2022.970486

Figure 2.

Figure 2

Currently available complement inhibitors used in clinical trials of neurologic and non-neurologic diseases (Created with BioRender.com).